Venture Capital New Investment

SEQONE GENOMICS closes €20M series A to accelerate the deployment of its genomic medicine platform

Monday 24 January, 2022

The round, led by Omnes, Merieux Equity Partners, together with the Software Club and existing investors, Elaia and IRDI Capital Investissement, will enable SeqOne Genomics to accelerate its international sales and the development of new collaborative genomic analysis tools to facilitate communications between different disciplines in the medical team, in order to improve patient outcomes in cancer and hereditary disease.